CN Stock MarketDetailed Quotes

300636 Jiangxi Synergy Pharmaceutical

Watchlist
  • 10.18
  • +0.36+3.67%
Noon Break Jun 11 11:30 CST
4.29BMarket Cap36.88P/E (TTM)

Jiangxi Synergy Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-6.47%206.45M
0.31%722.14M
5.94%559.66M
13.63%381.75M
22.79%220.75M
21.58%719.91M
23.43%528.27M
21.06%335.98M
30.89%179.77M
35.99%592.13M
Operating revenue
-6.47%206.45M
0.31%722.14M
5.94%559.66M
13.63%381.75M
22.79%220.75M
21.58%719.91M
23.43%528.27M
21.06%335.98M
30.89%179.77M
35.99%592.13M
Other operating revenue
----
8.95%1.43M
----
668.20%3.48M
----
-56.93%1.32M
----
-83.57%452.38K
----
110.54%3.06M
Total operating cost
-15.81%150.66M
-1.47%599.9M
5.31%476.32M
10.93%326.54M
19.92%178.96M
21.95%608.85M
27.42%452.32M
28.55%294.37M
30.98%149.24M
38.20%499.27M
Operating cost
-7.61%130.75M
-0.99%481.66M
2.98%384.57M
5.42%254.5M
13.57%141.52M
17.71%486.45M
24.93%373.42M
23.26%241.43M
27.04%124.61M
45.89%413.27M
Operating tax surcharges
-1.19%859.07K
53.22%3.66M
58.28%2.8M
50.19%1.75M
46.32%869.46K
31.48%2.39M
28.99%1.77M
28.90%1.16M
35.76%594.21K
21.24%1.82M
Operating expense
11.80%5.93M
42.15%26.26M
41.43%17.56M
30.28%11.84M
4.76%5.3M
2.45%18.47M
-6.62%12.42M
18.56%9.09M
25.72%5.06M
30.14%18.03M
Administration expense
-7.32%8.4M
4.95%34.57M
32.33%27.96M
48.03%19.05M
37.58%9.06M
38.59%32.94M
39.76%21.13M
37.54%12.87M
45.50%6.59M
37.52%23.77M
Financial expense
-285.55%-5.57M
-222.29%-9.4M
-277.69%-4.04M
-78.79%875.1K
235.71%3M
128.49%7.69M
15.74%2.28M
643.10%4.13M
2,087.68%893.86K
-66.61%3.36M
-Interest expense (Financial expense)
182.30%4.06M
28.53%9.9M
103.36%6.17M
24.43%4.41M
-17.67%1.44M
35.31%7.7M
-22.55%3.03M
34.25%3.55M
35.72%1.75M
-36.73%5.69M
-Interest Income (Financial expense)
-716.97%-9.01M
-488.68%-17.01M
-333.72%-8.9M
-113.17%-2.74M
-122.64%-1.1M
-48.24%-2.89M
-86.79%-2.05M
-48.65%-1.29M
19.01%-495.57K
-242.74%-1.95M
Research and development
-46.42%10.29M
3.68%63.15M
14.94%47.48M
49.93%38.53M
67.09%19.21M
56.10%60.91M
69.82%41.31M
75.53%25.7M
68.35%11.5M
10.54%39.02M
Credit Impairment Loss
-61.14%-2.53M
107.24%107.34K
-4.29%-1.47M
14.33%-404.71K
-20.41%-1.57M
28.18%-1.48M
12.45%-1.41M
85.27%-472.4K
38.77%-1.3M
-178.98%-2.07M
Asset Impairment Loss
-42.35%-7.92M
-162.12%-19.14M
-132.09%-993.64K
-192.21%-2.5M
---5.56M
-52.53%-7.3M
--3.1M
--2.71M
----
-134.90%-4.79M
Other net revenue
0.06%-6.76M
-111.91%-10.01M
60.17%5.88M
64.22%5.92M
-593.16%-6.77M
-4.62%-4.72M
508.91%3.67M
332.55%3.6M
26.85%-975.98K
-209.88%-4.51M
Fair value change income
----
----
----
----
----
-200.00%-255.58K
---481.44K
---566K
----
--255.58K
Invest income
----
159.55%567.88K
----
----
----
-4,832.31%-953.63K
-3,696.51%-724.75K
-1,461.92%-274.45K
----
-70.31%20.15K
Asset deal income
--0
-650.05%-1.32M
-404.46%-888.31K
----
--0
82.48%-176.09K
-23.50%-176.09K
----
----
41.73%-1.01M
Other revenue
904.91%3.69M
79.50%9.78M
174.18%9.23M
299.35%8.82M
12.58%366.76K
77.55%5.45M
44.02%3.37M
30.32%2.21M
-58.25%325.79K
-40.84%3.07M
Operating profit
40.02%49.03M
5.55%112.23M
12.05%89.22M
35.22%61.13M
18.48%35.02M
20.37%106.33M
8.16%79.63M
-3.80%45.21M
33.92%29.56M
12.90%88.34M
Add:Non operating Income
--0
1,490.37%354.08K
-69.79%6.73K
-69.79%6.73K
-69.79%6.73K
3,008,548.65%22.26K
3,008,548.65%22.26K
3,008,548.65%22.26K
--22.26K
--0.74
Less:Non operating expense
1.15%66.75K
-58.05%85.99K
19.98%65.99K
19.98%65.99K
19.98%65.99K
--205K
--55K
--55K
--55K
----
Total profit
40.07%48.97M
5.98%112.5M
12.02%89.16M
35.18%61.07M
18.41%34.96M
20.16%106.15M
8.12%79.59M
-3.86%45.18M
33.78%29.52M
13.17%88.34M
Less:Income tax cost
190.08%5.4M
18.88%6.52M
105.76%10.51M
59.18%4.04M
-30.91%1.86M
-24.08%5.48M
-27.78%5.11M
-43.12%2.54M
39.52%2.7M
-9.83%7.22M
Net profit
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
15.80%81.12M
Net profit from continuing operation
----
5.28%105.98M
5.59%78.65M
33.75%57.03M
----
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
15.80%81.12M
Net profit of parent company owners
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
15.80%81.12M
Earning per share
Basic earning per share
9.74%0.1037
-9.66%0.2786
-7.47%0.2143
18.93%0.1621
8.75%0.0945
17.40%0.3084
5.27%0.2316
-34.03%0.1363
-11.24%0.0869
-22.64%0.2627
Diluted earning per share
10.44%0.1037
-4.20%0.2786
-7.43%0.2144
28.31%0.1618
18.41%0.0939
21.02%0.2908
15.80%0.2316
-33.21%0.1261
-19.00%0.0793
-29.20%0.2403
Other composite income
Total composite income
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
15.80%81.12M
Total composite income of parent company owners
31.62%43.56M
5.28%105.98M
5.59%78.65M
33.75%57.03M
23.36%33.1M
24.10%100.67M
11.93%74.49M
0.26%42.64M
33.22%26.83M
15.80%81.12M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -6.47%206.45M0.31%722.14M5.94%559.66M13.63%381.75M22.79%220.75M21.58%719.91M23.43%528.27M21.06%335.98M30.89%179.77M35.99%592.13M
Operating revenue -6.47%206.45M0.31%722.14M5.94%559.66M13.63%381.75M22.79%220.75M21.58%719.91M23.43%528.27M21.06%335.98M30.89%179.77M35.99%592.13M
Other operating revenue ----8.95%1.43M----668.20%3.48M-----56.93%1.32M-----83.57%452.38K----110.54%3.06M
Total operating cost -15.81%150.66M-1.47%599.9M5.31%476.32M10.93%326.54M19.92%178.96M21.95%608.85M27.42%452.32M28.55%294.37M30.98%149.24M38.20%499.27M
Operating cost -7.61%130.75M-0.99%481.66M2.98%384.57M5.42%254.5M13.57%141.52M17.71%486.45M24.93%373.42M23.26%241.43M27.04%124.61M45.89%413.27M
Operating tax surcharges -1.19%859.07K53.22%3.66M58.28%2.8M50.19%1.75M46.32%869.46K31.48%2.39M28.99%1.77M28.90%1.16M35.76%594.21K21.24%1.82M
Operating expense 11.80%5.93M42.15%26.26M41.43%17.56M30.28%11.84M4.76%5.3M2.45%18.47M-6.62%12.42M18.56%9.09M25.72%5.06M30.14%18.03M
Administration expense -7.32%8.4M4.95%34.57M32.33%27.96M48.03%19.05M37.58%9.06M38.59%32.94M39.76%21.13M37.54%12.87M45.50%6.59M37.52%23.77M
Financial expense -285.55%-5.57M-222.29%-9.4M-277.69%-4.04M-78.79%875.1K235.71%3M128.49%7.69M15.74%2.28M643.10%4.13M2,087.68%893.86K-66.61%3.36M
-Interest expense (Financial expense) 182.30%4.06M28.53%9.9M103.36%6.17M24.43%4.41M-17.67%1.44M35.31%7.7M-22.55%3.03M34.25%3.55M35.72%1.75M-36.73%5.69M
-Interest Income (Financial expense) -716.97%-9.01M-488.68%-17.01M-333.72%-8.9M-113.17%-2.74M-122.64%-1.1M-48.24%-2.89M-86.79%-2.05M-48.65%-1.29M19.01%-495.57K-242.74%-1.95M
Research and development -46.42%10.29M3.68%63.15M14.94%47.48M49.93%38.53M67.09%19.21M56.10%60.91M69.82%41.31M75.53%25.7M68.35%11.5M10.54%39.02M
Credit Impairment Loss -61.14%-2.53M107.24%107.34K-4.29%-1.47M14.33%-404.71K-20.41%-1.57M28.18%-1.48M12.45%-1.41M85.27%-472.4K38.77%-1.3M-178.98%-2.07M
Asset Impairment Loss -42.35%-7.92M-162.12%-19.14M-132.09%-993.64K-192.21%-2.5M---5.56M-52.53%-7.3M--3.1M--2.71M-----134.90%-4.79M
Other net revenue 0.06%-6.76M-111.91%-10.01M60.17%5.88M64.22%5.92M-593.16%-6.77M-4.62%-4.72M508.91%3.67M332.55%3.6M26.85%-975.98K-209.88%-4.51M
Fair value change income ---------------------200.00%-255.58K---481.44K---566K------255.58K
Invest income ----159.55%567.88K-------------4,832.31%-953.63K-3,696.51%-724.75K-1,461.92%-274.45K-----70.31%20.15K
Asset deal income --0-650.05%-1.32M-404.46%-888.31K------082.48%-176.09K-23.50%-176.09K--------41.73%-1.01M
Other revenue 904.91%3.69M79.50%9.78M174.18%9.23M299.35%8.82M12.58%366.76K77.55%5.45M44.02%3.37M30.32%2.21M-58.25%325.79K-40.84%3.07M
Operating profit 40.02%49.03M5.55%112.23M12.05%89.22M35.22%61.13M18.48%35.02M20.37%106.33M8.16%79.63M-3.80%45.21M33.92%29.56M12.90%88.34M
Add:Non operating Income --01,490.37%354.08K-69.79%6.73K-69.79%6.73K-69.79%6.73K3,008,548.65%22.26K3,008,548.65%22.26K3,008,548.65%22.26K--22.26K--0.74
Less:Non operating expense 1.15%66.75K-58.05%85.99K19.98%65.99K19.98%65.99K19.98%65.99K--205K--55K--55K--55K----
Total profit 40.07%48.97M5.98%112.5M12.02%89.16M35.18%61.07M18.41%34.96M20.16%106.15M8.12%79.59M-3.86%45.18M33.78%29.52M13.17%88.34M
Less:Income tax cost 190.08%5.4M18.88%6.52M105.76%10.51M59.18%4.04M-30.91%1.86M-24.08%5.48M-27.78%5.11M-43.12%2.54M39.52%2.7M-9.83%7.22M
Net profit 31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M15.80%81.12M
Net profit from continuing operation ----5.28%105.98M5.59%78.65M33.75%57.03M----24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M15.80%81.12M
Net profit of parent company owners 31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M15.80%81.12M
Earning per share
Basic earning per share 9.74%0.1037-9.66%0.2786-7.47%0.214318.93%0.16218.75%0.094517.40%0.30845.27%0.2316-34.03%0.1363-11.24%0.0869-22.64%0.2627
Diluted earning per share 10.44%0.1037-4.20%0.2786-7.43%0.214428.31%0.161818.41%0.093921.02%0.290815.80%0.2316-33.21%0.1261-19.00%0.0793-29.20%0.2403
Other composite income
Total composite income 31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M15.80%81.12M
Total composite income of parent company owners 31.62%43.56M5.28%105.98M5.59%78.65M33.75%57.03M23.36%33.1M24.10%100.67M11.93%74.49M0.26%42.64M33.22%26.83M15.80%81.12M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg